Title: Clinical Observation of Astragalus,Erigeron in Treatment of 46 Patients with Idiopathic Nephrotic Syndrome
Abstract: Objective To investigate astragalus,erigeron in the treatment of adults with idiopathic nephrotic syndrome efficacy and mechanism. Methods Patients were randomly divided into two groups(treatment group and the control group). Control group using conventional hormone treatment. In the treatment group on the basis of conventional therapy,plus Astragalus,breviscapine joint static,before and after treatment were observed 24-hour urine protein,albumin(Alb),(Lipids including total cholesterol(TC),triglycerides(TG),high-density lipoprotein(HDL),low density lipoprotein(LDL)) changes. Results The treatment group and the control group before and after treatment in 24-hour urine protein,Alb,lipids have significantly changed. However,the treatment group compared with the control group,the treatment group were significantly improved. Conclusion Astragalus,breviscapine change nephrotic syndrome in patients with high blood lipids and reduce proteinuria,plasma albumin increased,so as to achieve remission for nephrotic syndrome,reducing the side effects of hormones and improve renal pathology,reduce inflammation of the kidney cells Damage to achieve significant role in the protection of the kidney.
Publication Year: 2008
Publication Date: 2008-01-01
Language: en
Type: article
Access and Citation
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot